No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2240 |
4. Check minimum number of eventsNone |
2240 |
5. Include endpointsNone |
2240 |
6. Filter based on genotype QC (FinnGen only) |
2240 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G90-G99
- Name in latin
- Aliae morbositates cerebri
Similar endpoints
↥List of similar endpoints to
Cerebral cysts
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 20739 | 9226 | 11265 |
| Only index persons | 15721 | 7529 | 8192 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.26 | 0.31 |
| Only index persons | 0.30 | 0.28 | 0.31 |
| Median age at first event (years) | |||
| Whole population | 52.04 | 47.69 | 55.28 |
| Only index persons | 49.56 | 44.95 | 53.80 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2240 | 1249 | 991 |
| Unadjusted period prevalence (%) | 0.43 | 0.43 | 0.44 |
| Median age at first event (years) | 49.33 | 41.94 | 58.65 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2036
- Matched controls
- 20361
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.0
ICD-10 Finland
Cerebral cysts
7074.3
323.0
539
*
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
+∞
323.0
436
*
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
323.0
318
*
G93.4
ICD-10 Finland
Encephalopathy, unspecified
+∞
299.6
280
*
G93.3
ICD-10 Finland
Postviral fatigue syndrome
329.2
259.5
258
9
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
33.7
202.7
268
91
S01EC01
ATC
acetazolamide; systemic
17.6
149.1
241
154
H47.1
ICD-10 Finland
Papilloedema, unspecified
84.4
145.8
163
21
AA1AD
NOMESCO Finland
CT of head and brain
4.1
137.9
661
2137
TAB00
NOMESCO Finland
Lumbar puncture
10.7
132.3
269
286
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.0
120.1
365
716
R51.80
ICD-10 Finland
Headache
3.9
105.7
515
1632
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.3
96.5
325
709
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.7
78.5
294
710
G93.99
ICD-10 Finland
Disorder of brain, unspecified
+∞
69.1
66
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.0
67.4
449
1734
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
65.4
399
1445
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
658.6
65.3
64
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
30.2
64.7
87
30
G93.8
ICD-10 Finland
Other specified disorders of brain
+∞
63.9
61
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
61.8
59
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.9
59.7
175
317
R53
ICD-10 Finland
Malaise and fatigue
2.6
56.5
512
2359
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.0
53.7
138
209
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
18.5
51.4
80
45
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.5
51.2
195
471
N03AX14
ATC
levetiracetam; systemic
7.2
48.2
121
177
N06AX16
ATC
venlafaxine; oral
2.7
44.8
357
1506
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
44.1
209
614
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
117.6
42.9
46
*
XCK00
NOMESCO Finland
Perimetry
3.9
42.8
189
523
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
42.7
287
1088
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
42.6
188
519
G93.90
ICD-10 Finland
Brain death
+∞
41.8
40
*
N03AX11
ATC
topiramate; oral
5.9
39.8
116
208
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.3
38.8
207
666
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
38.7
37
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
38.6
165
443
N03AX16
ATC
pregabalin; oral
2.2
38.5
467
2425
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.9
37.9
97
146
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
37.4
463
2421
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
37.1
297
1245
3480A
ICD-9 Finland
Other conditions of brain, Cerebral cysts
+∞
36.6
35
*
N03AX12
ATC
gabapentin; oral
2.5
36.5
329
1469
N03AF02
ATC
oxcarbazepine; oral
5.0
36.5
121
252
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
8.2
36.4
83
105
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
15.0
35.9
60
41
WX730
NOMESCO Finland
Conventional respirator
7.8
35.7
84
112
G93.5
ICD-10 Finland
Compression of brain
+∞
35.5
34
*
R42
ICD-10 Finland
Dizziness and giddiness
2.2
35.2
421
2161
N03AG01
ATC
valproic acid; systemic, rectal
3.3
35.1
191
623
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
34.2
553
3216
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.0
33.6
85
126
N05AH04
ATC
quetiapine; oral
2.2
33.5
395
2008
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.8
33.2
114
247
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
11.6
33.1
62
55
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.5
32.1
161
493
G44.2
ICD-10 Finland
Tension-type headache
2.4
31.8
303
1389
C03CA01
ATC
furosemide; systemic
2.0
31.8
497
2839
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
31.3
30
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
30.9
305
1422
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
162.5
30.7
32
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
30.3
29
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
29.6
773
5252
R41.0
ICD-10 Finland
Disorientation, unspecified
5.7
28.7
84
152
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.1
28.6
79
133
N05BA04
ATC
oxazepam; oral
1.9
28.4
493
2913
Z2445
NOMESCO Finland
Psychologist
3.6
28.3
134
392
C07AB07
ATC
bisoprolol; oral
1.7
28.1
795
5508
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.8
28.0
96
208
N06AB04
ATC
citalopram; systemic
2.0
27.8
444
2538
N06AX11
ATC
mirtazapine; oral
1.8
27.8
617
3958
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.8
27.3
79
141
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.0
27.3
170
605
N05CF01
ATC
zopiclone; oral
1.8
27.0
584
3707
N06AX21
ATC
duloxetine; oral
2.5
26.4
227
981
WX872
NOMESCO Finland
Intensive care
3.5
26.3
129
388
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
26.2
110
290
N03AX09
ATC
lamotrigine; oral
3.2
25.9
142
465
G91.0
ICD-10 Finland
Communicating hydrocephalus
263.8
25.7
26
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
136.7
25.7
27
*
CS494
NOMESCO Finland
Other visual field testing
5.9
25.5
72
125
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
25.2
318
1647
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
25.0
400
2280
F48.0
ICD-10 Finland
Neurasthenia
26.6
24.9
34
13
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.7
24.7
179
701
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
24.6
306
1574
L28
ICPC
Limited function/disability (L)
2.2
24.5
278
1373
N03AE01
ATC
clonazepam; systemic
3.1
24.4
138
461
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
24.2
200
846
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.2
24.1
134
443
WX930
NOMESCO Finland
Thepapeutic hypothermia
29.5
24.1
32
11
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
24.0
23
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
24.0
306
1592
R06.0
ICD-10 Finland
Dyspnoea
1.8
23.8
448
2698
A07AA11
ATC
rifaximin; oral
27.1
23.6
32
12
A06AD11
ATC
lactulose; oral
2.2
23.4
271
1351
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
23.1
173
690
C07AA05
ATC
propranolol; systemic
1.9
22.7
399
2341
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
7.2
22.6
55
78
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
22.6
168
670
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.6
22.5
171
689
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
7.1
22.4
55
79
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
5.8
22.4
64
113
R55
ICD-10 Finland
Syncope and collapse
2.4
22.2
209
943
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
8.4
21.9
48
58
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
21.8
280
1457
C03DA01
ATC
spironolactone; oral
2.4
21.7
203
914
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
116.3
21.6
23
*
N05BA01
ATC
diazepam; systemic, rectal
2.1
21.6
272
1401
A28
ICPC
Limited function/disability NOS
2.2
21.3
245
1214
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
21.3
126
433
N29
ICPC
Neurological sympt/complt other
6.0
20.9
58
99
YKA02
NOMESCO Finland
Excision of kidneys from cadaver donor
+∞
20.9
20
*
A02BC02
ATC
pantoprazole; systemic
1.6
20.8
1145
9194
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
20.4
217
1039
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.9
20.0
303
1680
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
20.0
122
431
G43.9
ICD-10 Finland
Migraine, unspecified
2.6
19.9
149
597
SPAT1301
SPAT
No procedures
1.6
19.8
597
4113
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.7
19.6
143
562
M03BX01
ATC
baclofen; systemic
6.3
19.6
52
84
AAF00
NOMESCO Finland
Ventriculostomy
21.8
19.5
28
13
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
11.4
19.5
36
32
H53.4
ICD-10 Finland
Visual field defects
5.3
19.4
60
117
N03AX18
ATC
lacosamide; systemic
10.7
19.4
37
35
R4150
NOMESCO Finland
Neuropsychological rehabilitation
9.2
19.4
40
44
N05AX08
ATC
risperidone; systemic
2.4
19.2
168
728
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
19.2
101
322
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
18.8
18
*
AAF40
NOMESCO Finland
Shunt of cyst of brain to peritoneum
+∞
18.8
18
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
18.8
421
2659
N06AB10
ATC
escitalopram; oral
1.8
18.7
407
2543
GBB00
NOMESCO Finland
Tracheostomy
7.0
18.7
46
67
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
18.6
121
442
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
191.7
18.6
19
*
R11
ICD-10 Finland
Nausea and vomiting
2.4
18.5
164
719
N02AX02
ATC
tramadol; systemic, rectal
1.6
18.5
725
5320
N03AF01
ATC
carbamazepine; oral, rectal
2.9
18.5
114
406
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
18.3
188
884
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
18.3
197
946
Z2446
NOMESCO Finland
Social worker
2.4
18.2
157
678
G41.9
ICD-10 Finland
Status epilepticus, unspecified
11.1
18.2
34
31
H02AB06
ATC
prednisolone; systemic
1.5
18.0
830
6314
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.7
17.9
41
54
N28
ICPC
Limited function/disability (N)
6.8
17.6
44
66
H53.2
ICD-10 Finland
Diplopia
4.1
17.5
68
169
K90
ICPC
Stroke/cerebrovascular accident
4.5
17.1
60
135
WX704
NOMESCO Finland
Intubation
2.4
16.9
148
642
G43.3
ICD-10 Finland
Complicated migraine
4.6
16.7
58
129
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
11.2
16.7
31
28
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
+∞
16.7
16
*
N06AX12
ATC
bupropion; oral
2.3
16.5
151
671
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
13.5
16.5
28
21
N05BA09
ATC
clobazam; oral
9.6
16.4
33
35
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
16.3
105
384
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.0
16.3
52
106
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
16.2
662
4868
ZXD05
NOMESCO Finland
Urgent procedure
1.6
16.1
593
4253
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.6
16.1
55
121
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
16.0
339
2094
183
Kela drug reimbursment
Lamotrigin and topiramate
6.3
15.9
42
68
AA1AA
NOMESCO Finland
Head X-ray examination
12.3
15.8
28
23
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.2
15.8
49
97
G45.3
ICD-10 Finland
Amaurosis fugax
33.6
15.7
20
6
N18
ICPC
Paralysis/weakness
5.8
15.7
44
77
R4120
NOMESCO Finland
Occupational therapy
2.5
15.7
124
512
R51
ICD-10 Finland
Headache
2.5
15.6
122
500
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
15.6
354
2231
H47.3
ICD-10 Finland
Other disorders of optic disc
22.2
15.5
22
10
M35.7
ICD-10 Finland
Hypermobility syndrome
5.0
15.5
49
99
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
15.5
187
945
N06AB06
ATC
sertraline; oral
1.9
15.4
228
1244
A04
ICPC
Weakness/tiredness general
1.9
15.4
254
1444
C09AA05
ATC
ramipril; oral
1.7
15.3
365
2333
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
7.6
15.2
35
47
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.6
15.2
35
47
N05AH03
ATC
olanzapine; systemic
2.3
15.1
137
609
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
14.8
417
2786
WX882
NOMESCO Finland
High dependency care
3.3
14.8
74
229
A02BC05
ATC
esomeprazole; systemic
1.5
14.7
675
5065
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
14.6
14
*
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
+∞
14.6
14
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
14.6
76
242
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
14.6
61
163
SPAT1229
SPAT
Assessment of need for aid
2.3
14.6
136
612
E66.8
ICD-10 Finland
Other obesity
2.6
14.5
110
445
R1250
NOMESCO Finland
Evaluation of functional capability
4.2
14.5
54
130
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
14.4
79
261
H02AB09
ATC
hydrocortisone; systemic
3.5
14.4
66
191
G44.8
ICD-10 Finland
Other specified headache syndromes
5.8
14.4
40
70
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
14.3
142
658
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
14.3
250
1449
K72.1
ICD-10 Finland
Chronic hepatic failure
42.8
14.1
17
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
14.0
163
809
G47.3
ICD-10 Finland
Sleep apnoea
1.7
13.9
344
2215
N01
ICPC
Headache
1.9
13.8
230
1308
XF404
NOMESCO Finland
Ambulatory ECG
2.1
13.6
160
799
WX892
NOMESCO Finland
Monitored bed care
2.2
13.6
140
661
AAF15
NOMESCO Finland
Ventriculoatrial shunt
75.6
13.6
15
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
13.6
187
995
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
13.6
164
827
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
13.5
100
399
SPAT1255
SPAT
Intravenous administration of medicine
2.3
13.5
123
546
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
13.5
163
822
N99
ICPC
Neurological disease other
6.8
13.4
33
49
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.5
13.4
62
181
K70.4
ICD-10 Finland
Alcoholic hepatic failure
11.5
13.3
24
21
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
13.3
462
3245
N04BC09
ATC
rotigotine; transdermal
10.5
13.2
25
24
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.5
13.1
38
70
A98
ICPC
Health maint/preventive medicine
0.6
13.1
1673
17952
I47.2
ICD-10 Finland
Ventricular tachycardia
3.9
13.1
53
138
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.6
13.1
98
394
G41.0
ICD-10 Finland
Grand mal status epilepticus
28.5
13.0
17
6
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
12.9
273
1677
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
12.9
102
420
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.9
12.9
77
270
H03AA01
ATC
levothyroxine sodium; systemic
1.6
12.9
385
2599
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
12.8
113
495
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
12.8
107
456
S06.0
ICD-10 Finland
Concussion
1.9
12.7
192
1056
C07AB02
ATC
metoprolol; systemic
1.7
12.7
313
2007
YJA10
NOMESCO Finland
Excision of liver from cadaver donor
+∞
12.5
12
*
M79.7
ICD-10 Finland
Fibromyalgia
3.1
12.5
68
225
R4110
NOMESCO Finland
Physiotherapy
1.5
12.5
434
3042
ZX120
NOMESCO Finland
Intravenous
2.0
12.5
172
914
G41.2
ICD-10 Finland
Complex partial status epilepticus
20.2
12.5
18
9
TK800
NOMESCO Finland
Hemodialysis
3.9
12.4
50
130
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
130.8
12.4
13
*
Q04.6
ICD-10 Finland
Congenital cerebral cysts
130.8
12.4
13
*
Z3231
NOMESCO Finland
Registered nurse
1.5
12.4
478
3428
M54.2
ICD-10 Finland
Cervicalgia
2.2
12.4
128
603
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.4
12.3
59
178
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.6
12.2
89
354
A02BC01
ATC
omeprazole; systemic
1.5
12.1
463
3316
N06AX22
ATC
agomelatine; oral
3.6
12.1
54
154
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
12.0
128
614
R51.81
ICD-10 Finland
Facial pain NOS
3.8
11.9
50
135
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
11.9
168
904
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
11.9
101
433
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
11.8
215
1261
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.0
11.8
145
739
N04BC05
ATC
pramipexole; oral
2.2
11.8
117
543
I46.9
ICD-10 Finland
Cardiac arrest, unspecified
9.0
11.7
24
27
XA400
NOMESCO Finland
EEG
9.7
11.7
23
24
Z3226
NOMESCO Finland
Physiotherapist
1.6
11.7
319
2101
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
11.7
185
1036
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
16.5
11.7
18
11
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
11.5
155
820
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
11.5
11
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
11.4
401
2811
SPAT1240
SPAT
Therapeutic discussion
1.8
11.4
213
1257
N06AB05
ATC
paroxetine; oral
2.2
11.4
113
525
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
11.4
301
1968
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
11.4
353
2403
R13
ICD-10 Finland
Dysphagia
2.2
11.3
111
514
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
11.3
119
570
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
11.2
266
1688
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.3
11.2
105
473
R18
ICD-10 Finland
Ascites
4.0
11.2
43
108
N06AX26
ATC
vortioxetine; oral
2.2
11.2
120
576
N06BA07
ATC
modafinil; oral
12.8
11.1
19
15
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
11.1
127
629
J01FF01
ATC
clindamycin; systemic
1.5
11.0
454
3295
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
9.3
11.0
22
24
Z02.7
ICD-10 Finland
Issue of medical certificate
2.2
11.0
112
528
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
43.5
10.9
13
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.0
10.9
29
49
N02AA05
ATC
oxycodone; systemic
1.7
10.9
215
1294
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
10.8
439
3170
SPAT1216
SPAT
Assessment of functional ability
1.7
10.8
226
1383
3007
Kela drug reimbursment
Erenumab and fremanezumab
4.6
10.8
36
79
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
10.8
71
265
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
9.6
10.7
21
22
H47.2
ICD-10 Finland
Optic atrophy
9.6
10.7
21
22
E66.9
ICD-10 Finland
Obesity, unspecified
2.7
10.7
71
266
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.7
10.7
46
128
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
10.7
715
5692
M79.6
ICD-10 Finland
Pain in limb
1.4
10.7
581
4454
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
10.6
148
789
G40.10
ICD-10 Finland
Simple partial seizures
6.3
10.6
27
43
P01
ICPC
Feeling anxious/nervous/tense
1.7
10.6
216
1313
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
10.6
315
2120
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
10.6
169
950
ZY010
NOMESCO Finland
Hospital outpatient
2.2
10.6
107
503
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
10.6
759
6111
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.9
10.5
61
212
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
10.5
221
1356
G93.9
ICD-10 Finland
Disorder of brain, unspecified
+∞
10.4
10
*
A02BA02
ATC
ranitidine; systemic
1.6
10.4
304
2035
N05AB03
ATC
perphenazine; systemic, rectal
2.6
10.4
73
284
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
10.4
228
1414
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
10.3
92
407
K72.9
ICD-10 Finland
Hepatic failure, unspecified
8.2
10.3
22
27
N06AB03
ATC
fluoxetine; oral
1.7
10.3
215
1316
F05.9
ICD-10 Finland
Delirium, unspecified
3.9
10.3
41
107
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.3
300
2007
T82
ICPC
Obesity
2.7
10.3
70
269
P76
ICPC
Depressive disorder
2.0
10.2
124
628
AN1
HP
Coronary angiography
1.8
10.2
169
962
N05CD07
ATC
temazepam; oral
1.8
10.1
188
1111
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
10.1
78
320
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
10.1
298
2003
N06AA09
ATC
amitriptyline; systemic
1.9
10.0
147
799
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.9
10.0
40
105
N06AA10
ATC
nortriptyline; systemic
3.5
9.9
45
131
F32.1
ICD-10 Finland
Moderate depressive episode
2.1
9.9
109
530
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.7
9.9
42
116
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.9
9.9
31
64
R03AC02
ATC
salbutamol; inhalant
1.4
9.9
929
7792
E23.06
ICD-10 Finland
Empty sella
26.1
9.8
13
5
W19
ICD-10 Finland
Unspecified fall
1.8
9.7
160
909
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.8
9.7
62
229
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
9.7
141
767
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
9.7
170
987
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
55.3
9.6
11
*
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
55.3
9.6
11
*
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.0
9.6
55
188
L01AX03
ATC
temozolomide; systemic
7.8
9.6
21
27
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
9.5
94
436
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
9.5
179
1062
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.5
448
3331
C09CA06
ATC
candesartan; oral
1.5
9.5
318
2198
B01AA03
ATC
warfarin; systemic
1.6
9.4
278
1865
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
9.4
98
466
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
9.4
270
1797
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
9.4
591
4630
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
9.4
9
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
9.4
148
830
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.6
9.3
40
112
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.7
9.3
60
224
I25.2
ICD-10 Finland
Old myocardial infarction
2.0
9.3
111
560
A01
ICPC
Pain general/multiple sites
1.9
9.2
125
661
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.0
9.2
51
173
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
9.2
113
578
R4190
NOMESCO Finland
Nutritional therapy
2.4
9.2
76
325
M54.5
ICD-10 Finland
Low back pain
1.4
9.2
538
4159
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
9.1
138
759
A04AA01
ATC
ondansetron; systemic, rectal
2.1
9.1
104
516
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
9.1
286
1947
SPAT1252
SPAT
Overall medication plan or its review
2.1
9.1
105
524
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
15.6
9.0
14
9
Z56.7
ICD-10 Finland
Other and unspecified problems related to employment
9.1
9.0
18
20
ZXY02
NOMESCO Finland
Neuropsychologist
7.1
9.0
21
30
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.8
9.0
36
95
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
9.0
582
4571
R52.2
ICD-10 Finland
Other chronic pain
2.5
9.0
68
277
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
8.9
184
1121
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
8.9
538
4175
SPAT1153
SPAT
Removal of sutures
1.4
8.9
489
3730
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
24.1
8.9
12
5
N05AA02
ATC
levomepromazine; systemic
2.3
8.9
79
348
H57.1
ICD-10 Finland
Ocular pain
2.7
8.9
60
229
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.5
8.8
30
68
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.2
8.8
84
383
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.7
8.8
37
102
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.8
126
683
R52.9
ICD-10 Finland
Pain, unspecified
1.8
8.8
143
811
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
8.8
84
386
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
8.8
292
2015
G40
ICD-10 Finland
Epilepsy
5.4
8.7
25
47
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.9
8.7
34
88
WX900
NOMESCO Finland
Resuscitation
7.2
8.7
20
28
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
8.7
84
388
M54.6
ICD-10 Finland
Pain in thoracic spine
2.0
8.7
113
591
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.5
8.7
29
65
G43.8
ICD-10 Finland
Other migraine
3.6
8.6
37
104
K91
ICPC
Cerebrovascular disease
5.1
8.6
26
52
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
8.6
93
451
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.3
8.6
30
70
A05
ICPC
Feeling ill
1.9
8.6
118
628
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
5.5
8.6
24
44
K07.60
ICD-10 Finland
Snapping jaw
2.1
8.6
97
480
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
8.5
142
811
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.4
8.5
21
33
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
20.1
8.5
12
6
R40.2
ICD-10 Finland
Coma, unspecified
5.2
8.5
25
49
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
8.5
99
498
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.5
186
1156
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.9
8.4
49
171
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.7
8.4
54
201
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
8.4
567
4479
SPAT1263
SPAT
Sampling
1.3
8.4
744
6134
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
8.3
104
535
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.7
8.3
35
97
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
8.3
8
*
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
8.3
8
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
8.3
79
364
P29
ICPC
Psychological sympt/compl other
1.9
8.3
112
595
N30.0
ICD-10 Finland
Acute cystitis
1.6
8.3
221
1444
M79.1
ICD-10 Finland
Myalgia
1.6
8.2
209
1350
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
4.4
8.2
28
64
G44.0
ICD-10 Finland
Cluster headache syndrome
4.4
8.2
28
64
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.2
1099
9611
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.0
8.2
47
161
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
8.2
382
2823
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
4.2
8.2
29
69
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
8.1
64
269
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
8.1
100
513
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.1
609
4892
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
8.1
171
1052
N02BE01
ATC
paracetamol; systemic, rectal
1.4
8.0
1541
14181
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
8.0
789
6597
AAK00
NOMESCO Finland
Cranioplasty
22.1
8.0
11
5
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
22.1
8.0
11
5
Z00.0
ICD-10 Finland
General medical examination
1.5
8.0
301
2131
N02CD01
ATC
erenumab; parenteral
4.6
8.0
26
57
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.1
8.0
42
139
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.6
8.0
34
96
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
7.9
161
976
UJF32
NOMESCO Finland
Coloscopy
1.4
7.9
363
2675
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.0
7.9
43
146
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
7.9
75
344
J45.8
ICD-10 Finland
Mixed asthma
2.7
7.9
52
199
P03
ICPC
Feeling depressed
1.7
7.8
170
1051
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
7.8
116
637
K92.1
ICD-10 Finland
Melaena
2.1
7.8
85
415
P20
ICPC
Memory disturbance
1.8
7.8
138
804
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
7.8
100
521
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
10.8
7.8
14
13
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
7.8
176
1103
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.8
7.8
24
50
K76.7
ICD-10 Finland
Hepatorenal syndrome
15.1
7.7
12
8
127
Kela drug reimbursment
Transplant complication
3.4
7.7
35
104
N05AX12
ATC
aripiprazole; systemic
2.2
7.7
79
375
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
5.3
7.7
22
42
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
7.7
215
1423
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.1
7.7
28
69
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.6
7.7
21
38
E87.6
ICD-10 Finland
Hypokalaemia
2.8
7.7
47
172
E23.00
ICD-10 Finland
Panhypopituitarism
7.4
7.7
17
23
N17
ICPC
Vertigo/dizziness
1.7
7.6
165
1019
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.7
7.6
24
51
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
25.1
7.6
10
*
ZXC95
NOMESCO Finland
Use of surgical navigator
4.0
7.6
28
70
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
5.2
7.5
22
43
H01AC01
ATC
somatropin; parenteral
8.9
7.5
15
17
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
10.1
7.5
14
14
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
7.5
53
210
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.4
7.5
21
39
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
7.5
157
960
XF402
NOMESCO Finland
ECG with work load test
1.7
7.5
149
900
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
7.5
256
1772
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.6
7.5
32
91
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.6
7.5
31
86
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
7.4
122
692
N03AB02
ATC
phenytoin; systemic
4.4
7.4
25
57
G92
ICD-10 Finland
Toxic encephalopathy
80.4
7.4
8
*
ABB20
NOMESCO Finland
Drainage of intra- or extramedullary cyst of spinal canal
80.4
7.4
8
*
N05BA12
ATC
alprazolam; oral
1.7
7.4
158
976
I50.0
ICD-10 Finland
Congestive heart failure
1.9
7.4
99
526
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.7
7.4
47
174
H02AB04
ATC
methylprednisolone; systemic
1.6
7.4
213
1420
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
7.3
313
2271
N06AG02
ATC
moclobemide; oral
2.2
7.3
71
328
G90.0
ICD-10 Finland
Idiopathic peripheral autonomic neuropathy
+∞
7.3
7
*
G90.2
ICD-10 Finland
Horner syndrome
+∞
7.3
7
*
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
+∞
7.3
7
*
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
10.9
7.3
13
12
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.8
7.3
115
644
N07AA02
ATC
pyridostigmine; systemic
9.4
7.3
14
15
G81.9
ICD-10 Finland
Hemiplegia, unspecified
4.9
7.3
22
45
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.3
292
2093
J01DB01
ATC
cefalexin; oral
1.3
7.3
1501
13826
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
7.3
174
1107
205
Kela drug reimbursment
Chronic hypertension
1.4
7.2
366
2740
J01EA01
ATC
trimethoprim; systemic
1.4
7.2
395
3001
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
15.8
7.2
11
7
N06AX05
ATC
trazodone; oral
2.7
7.2
46
171
G54.0
ICD-10 Finland
Brachial plexus disorders
2.7
7.2
46
171
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
7.2
118
671
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.1
7.2
26
64
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.1
7.2
26
64
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.6
7.2
50
196
N05BE01
ATC
buspirone; oral
2.5
7.2
51
204
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
30.1
7.1
9
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
30.1
7.1
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
7.1
112
626
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.3
7.1
62
272
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.1
7.1
75
361
UJD02
NOMESCO Finland
Gastroscopy
2.1
7.1
75
361
A46
ICD-10 Finland
Erysipelas
1.6
7.1
195
1283
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.1
342
2539
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
7.0
104
572
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
7.0
7.0
16
23
RD210
NOMESCO Finland
NA
2.7
7.0
46
176
I21.00
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
4.1
7.0
25
61
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.6
7.0
29
81
R21
ICPC
Throat symptom/complaint
1.4
7.0
381
2892
M54.1
ICD-10 Finland
Radiculopathy
2.3
6.9
59
259
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
6.9
109
613
R06AE07
ATC
cetirizine; oral
1.3
6.9
741
6229
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
6.9
135
811
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
7.5
6.9
15
20
Z08
ICPC
Social welfare problem
3.9
6.9
26
67
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.8
159
1004
R5110
SPAT
NA
2.9
6.8
40
142
A02BC03
ATC
lansoprazole; oral
1.4
6.8
425
3297
SPAT1310
SPAT
Counselling related to known health issue
1.3
6.8
525
4215
N06BA04
ATC
methylphenidate; oral
2.3
6.8
57
247
AAK80
NOMESCO Finland
Partial excision of skull cap
40.2
6.8
8
*
S09
ICPC
Infected finger/toe
2.5
6.8
49
199
SPAT1260
SPAT
Consultation of another employee
1.4
6.8
284
2053
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.3
6.7
31
94
P74
ICPC
Anxiety disorder/anxiety state
2.1
6.7
70
336
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
6.7
60
269
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
6.7
33
105
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.7
6.7
21
45
R4130
NOMESCO Finland
Speech therapy
2.9
6.7
39
138
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.7
621
5114
R1260
NOMESCO Finland
Evaluation of communicative skills
3.6
6.7
28
79
H93.1
ICD-10 Finland
Tinnitus
1.8
6.7
101
561
N18.8
ICD-10 Finland
Other chronic renal failure
2.6
6.6
44
170
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
6.6
129
776
SPAT1254
SPAT
Administration of medicine
1.5
6.6
229
1591
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
6.6
132
800
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
4.0
6.6
24
60
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
4.0
6.6
24
60
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.0
6.6
24
60
N05AB04
ATC
prochlorperazine; systemic, rectal
2.9
6.6
36
124
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.1
6.6
73
359
N05CF02
ATC
zolpidem; oral
1.5
6.6
263
1885
J96.0
ICD-10 Finland
Acute respiratory failure
3.7
6.6
26
70
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
6.6
84
439
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
8.7
6.5
13
15
A08
ICPC
Swelling
2.3
6.5
56
247
G50.1
ICD-10 Finland
Atypical facial pain
3.2
6.5
32
102
E66.0
ICD-10 Finland
Obesity due to excess calories
4.3
6.5
22
51
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
10.0
6.5
12
12
L29
ICPC
Musculoskeletal sympt/complt other
1.8
6.5
107
610
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.9
6.5
96
529
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.5
107
611
B01AC04
ATC
clopidogrel; oral
1.6
6.5
183
1212
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.2
6.5
31
97
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.3
6.5
58
260
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.5
6.5
47
191
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.5
6.5
47
191
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
6.5
68
328
B81
ICPC
Anaemia vit B12/folate deficiency
2.3
6.5
55
240
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.3
6.5
30
92
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.4
478
3811
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
70.1
6.4
7
*
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
70.1
6.4
7
*
G90.9
ICD-10 Finland
Disorder of autonomic nervous system, unspecified
70.1
6.4
7
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.3
6.4
22
52
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
6.4
153
974
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
6.4
104
590
A29
ICPC
General symptom/complaint other
1.6
6.4
162
1045
H52.2
ICD-10 Finland
Astigmatism
3.1
6.4
32
104
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.4
6.4
52
224
C09AA02
ATC
enalapril; systemic
1.4
6.4
267
1932
N02CD03
ATC
fremanezumab; systemic
4.9
6.4
19
39
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
6.3
76
387
NXL00
NOMESCO Finland
Biopsy of muscle
8.2
6.3
13
16
R27.0
ICD-10 Finland
Ataxia, unspecified
8.2
6.3
13
16
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
8.2
6.3
13
16
81
HP
Angiography of the heart and coronary arteries
1.9
6.3
86
459
N05AD01
ATC
haloperidol; systemic
2.3
6.3
55
246
A86
ICD-10 Finland
Unspecified viral encephalitis
6.0
6.3
16
27
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
11.1
6.3
11
10
F41.00
ICD-10 Finland
Moderate panic disorder
2.8
6.3
37
133
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.7
6.3
25
68
R33
ICD-10 Finland
Retention of urine
1.7
6.3
112
657
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.5
6.3
45
182
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
+∞
6.3
6
*
YFA50
NOMESCO Finland
Excision of heart for preparation of homograft
+∞
6.3
6
*
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
+∞
6.3
6
*
F34.1
ICD-10 Finland
Dysthymia
2.1
6.2
64
306
S97
ICPC
Chronic ulcer skin
2.0
6.2
75
383
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
7.0
6.2
14
20
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.2
224
1569
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.9
6.2
34
118
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.9
6.2
34
118
Z31.5
ICD-10 Finland
Genetic counselling
1.9
6.2
89
486
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.3
6.2
51
222
G04BD07
ATC
tolterodine; oral
2.1
6.2
68
335
G03.9
ICD-10 Finland
Meningitis, unspecified
6.3
6.2
15
24
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
2.8
6.1
36
129
R06.4
ICD-10 Finland
Hyperventilation
3.0
6.1
33
113
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
6.1
53
235
Z94.4
ICD-10 Finland
Liver transplant status
7.7
6.1
13
17
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.1
85
460
XF602
NOMESCO Finland
Bloodpressure monitoring
4.2
6.1
21
50
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
3.6
6.1
25
70
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
12.6
6.1
10
8
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
8.6
6.1
12
14
J01CA08
ATC
pivmecillinam; oral
1.3
6.1
612
5086
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
4.9
6.0
18
37
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
6.0
185
1252
G04BD04
ATC
oxybutynin; oral, transdermal
2.0
6.0
74
383
L17
ICPC
Foot/toe symptom/complaint
1.4
6.0
371
2870
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.1
6.0
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
353
382
10.78
302.39
1.5
1.2
mg/l
444.2
508.0
0.70
343
356
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
329
345
11.01
287.87
1.4
1.2
mmol/l
3.7
3.7
0.41
311
322
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
309
334
10.57
263.97
1.5
1.3
e6/l
274.3
1986.4
1.09
272
266
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
309
334
10.57
263.97
1.5
1.2
e6/l
10.0
33.1
0.73
261
255
(3044290) Cell count panel - Cerebral spinal fluid
269
321
9.39
212.23
1.4
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
221
326
7.41
144.77
6.9
3.0
umol/l
42.9
34.0
3.58
184
280
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
128
113
11.95
124.23
1.3
1.2
mmol/l
1.8
2.0
1.59
120
104
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
926
4408
2.88
123.51
2.8
2.1
u/l
223.3
263.5
0.37
893
4142
(3036481) Cortisol [Moles/volume] in Serum or Plasma
478
1607
3.51
115.61
2.3
2.0
nmol/l
393.4
373.4
0.59
446
1472
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
127
125
10.71
114.50
1.6
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
132
148
9.41
108.19
1.2
1.1
mg/l
44.9
39.7
0.17
114
118
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
129
144
9.44
106.06
1.1
1.0
mg/l
306.5
257.9
0.26
112
121
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
141
184
8.11
102.29
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
139
193
7.61
95.54
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
128
164
8.22
94.22
1.1
1.0
—
—
—
0
0
(4027681)
111
121
9.60
92.81
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
120
146
8.63
92.13
1.1
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
123
155
8.34
91.77
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
124
163
7.99
89.29
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
574
2506
2.74
85.38
4.8
3.6
mmol/l
0.8
0.8
0.59
536
2353
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
86
75
11.88
83.88
1.6
1.1
%
57.2
72.7
—
9
12
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
96
106
9.42
79.41
1.2
1.0
u/l
1.1
1.1
0.03
45
49
(3005719) IgG [Mass/volume] in Serum or Plasma
361
1285
3.16
77.43
2.5
2.7
g/l
10.6
10.7
0.12
326
1178
(3020779) Urea [Moles/volume] in Serum or Plasma
378
1383
3.09
77.32
9.5
7.8
mmol/l
8.8
9.3
0.72
359
1322
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
332
1174
3.15
71.72
2.6
2.3
au/ml
25.5
20.5
—
10
75
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1207
7836
2.17
69.18
9.8
6.5
mmol/l
1.2
1.2
1.97
1028
6610
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
307
1075
3.15
67.23
1.4
1.3
au/ml
40.7
54.0
—
8
46
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1114
7070
2.15
66.97
10.2
5.9
mmol/l
1.2
1.2
1.50
1039
6415
(3018677) aPTT in Platelet poor plasma by Coagulation assay
499
2276
2.53
66.03
2.7
2.2
s
29.7
29.9
0.18
484
2193
(3003458) Phosphate [Moles/volume] in Serum or Plasma
459
2039
2.57
64.01
8.0
6.0
mmol/l
1.1
1.1
1.39
438
1889
(3013826) Glucose [Moles/volume] in Serum or Plasma
1387
9743
2.11
61.77
7.8
4.6
mmol/l
6.6
6.6
0.00
1309
8991
(3024561) Albumin [Mass/volume] in Serum or Plasma
1058
6847
2.03
57.50
6.9
4.7
g/l
35.2
35.9
3.51
986
6380
(3003396) Base excess in Arterial blood by calculation
378
1672
2.52
52.36
10.7
8.4
mmol/l
1.0
1.1
0.19
284
1279
(3027801) Oxygen [Partial pressure] in Arterial blood
377
1676
2.50
51.61
10.8
8.4
kpa
13.2
12.3
2.34
359
1597
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
377
1676
2.50
51.61
10.8
8.4
kpa
5.0
5.1
0.97
360
1594
(3032080) INR in Blood by Coagulation assay
957
6161
1.97
50.97
9.9
8.9
inr
1.2
1.2
1.85
293
1895
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
58
60
9.90
50.22
1.3
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
343
1483
2.55
49.69
11.4
9.0
%
95.9
95.5
0.43
331
1429
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
818
5116
1.94
46.35
3.7
2.5
u/l
61.4
56.7
0.69
769
4738
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1198
8495
1.88
45.97
8.3
5.9
umol/l
12.1
11.7
0.22
1148
8016
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
901
5838
1.91
45.73
4.2
3.3
ng/l
47.3
58.1
0.42
563
3619
(3008152) Bicarbonate [Moles/volume] in Arterial blood
239
897
2.86
45.59
14.0
7.7
mmol/l
24.1
24.4
0.49
226
833
(3019060) Gas panel - Arterial blood
252
973
2.79
45.58
9.3
5.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
142
397
3.75
43.89
1.4
1.3
u/ml
289.1
248.9
0.78
99
244
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
139
386
3.77
43.38
1.6
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
309
1357
2.48
42.96
12.3
9.4
g/l
123.5
123.4
0.03
298
1300
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
67
100
6.88
42.96
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
89
7.25
42.46
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
140
416
3.52
39.48
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
449
2402
2.09
38.57
1.5
1.3
titre
375.6
491.4
1.20
90
483
(3020891) Body temperature
167
562
3.13
38.53
8.5
4.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
501
2794
2.02
38.39
1.9
1.7
nmol/l
1220.9
1163.1
0.70
407
2117
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
126
360
3.65
37.68
1.6
1.4
u/ml
96.6
118.0
0.80
39
61
(3021447) Carbon dioxide [Partial pressure] in Venous blood
312
1460
2.32
37.36
6.2
3.9
kpa
5.6
5.9
3.34
303
1414
(3023368) Bacteria identified in Blood by Culture
681
4253
1.86
37.03
5.0
4.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
310
1455
2.31
36.83
6.3
3.9
mmol/l
1.4
1.9
1.23
235
1152
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
50
65
7.85
36.20
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
125
372
3.50
35.14
3.8
3.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
186
702
2.80
34.89
1.8
2.0
u/l
39.6
39.4
0.05
167
639
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
248
1094
2.42
33.80
3.4
3.3
pmol/l
4.5
4.6
0.42
219
978
(3014576) Chloride [Moles/volume] in Serum or Plasma
361
1864
2.12
33.69
9.5
7.3
mmol/l
104.9
104.5
0.88
355
1825
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
551
3322
1.87
32.87
1.7
1.7
pmol/l
454.1
32416435.0
3.08
470
2798
(3018418) pH of Serum or Plasma
701
4572
1.78
32.18
5.2
3.8
ph
7.4
7.4
0.67
161
866
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
833
5711
1.73
32.04
4.9
3.1
u/l
50.5
32.0
0.82
794
5427
(3048929) Epstein Barr virus Ab [Presence] in Serum
181
707
2.70
31.73
1.4
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
82
195
4.33
31.60
1.5
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
31
26
12.08
30.79
1.1
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
67
139
4.94
30.52
1.9
3.5
mu/l
21.9
24.2
0.31
67
133
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
59
110
5.48
30.29
1.1
1.1
nmol/l
0.3
5.2
—
6
21
(3008295) Osmolality of Serum or Plasma
74
169
4.49
30.02
1.4
1.6
mosm/kgh2o
285.3
282.9
0.39
68
131
(3015377) Calcium [Moles/volume] in Serum or Plasma
787
5385
1.71
30.02
3.4
3.2
mmol/l
2.3
2.3
2.39
705
4757
(3014111) Lactate [Moles/volume] in Serum or Plasma
275
1334
2.21
29.89
8.6
7.7
mmol/l
1.5
1.4
0.97
257
1280
(3010421) pH of Blood
131
446
3.06
29.56
4.6
4.2
ph
7.4
7.4
0.70
107
363
(3009466) Valproate [Moles/volume] in Serum or Plasma
95
265
3.70
29.42
4.9
5.8
umol/l
370.5
373.1
0.06
83
236
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
225
1017
2.35
28.90
9.9
8.1
mmol/l
23.8
24.8
3.47
219
1010
(3028026) IgM [Mass/volume] in Serum or Plasma
225
1018
2.35
28.83
1.9
1.8
g/l
1.3
1.4
0.74
210
935
(3026008) Bacteria identified in Urine by Culture
709
4765
1.71
28.59
3.6
2.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
127
434
3.04
28.47
8.8
4.1
mmol/l
3.9
3.9
0.14
121
403
(3012501) Base excess in Blood by calculation
113
369
3.17
27.37
4.7
4.4
mmol/l
2.0
2.4
0.74
65
238
(3013290) Carbon dioxide [Partial pressure] in Blood
113
370
3.16
27.25
4.7
4.4
kpa
4.8
5.0
1.60
107
364
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
273
1371
2.13
27.07
1.3
1.2
iu/ml
82.6
149.7
3.41
108
543
(3015171) Extractable nuclear Ab [Units/volume] in Serum
165
666
2.59
27.03
1.4
1.2
u/ml
0.5
1.0
0.54
15
61
(3000991) Gas panel - Venous blood
264
1311
2.15
26.94
11.6
9.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
944
6923
1.63
26.71
2.9
2.2
nmol/l
72.3
74.7
1.49
874
6296
(3027315) Oxygen [Partial pressure] in Blood
112
370
3.13
26.61
4.7
4.4
kpa
9.3
8.6
3.81
106
364
(42870588) Differential panel, method unspecified - Blood
822
5834
1.65
26.46
7.1
5.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
320
1726
2.00
26.09
3.6
4.1
u/l
250.7
247.3
0.08
297
1634
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1558
12962
1.66
25.98
9.8
7.0
u/l
79.3
77.2
0.98
1487
12175
(3006315) Basophils [#/volume] in Blood
1140
8793
1.60
25.92
7.3
5.8
e9/l
0.0
0.0
0.45
1048
7638
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
285
1480
2.06
25.80
3.6
2.3
g/l
0.2
0.2
2.78
263
1377
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
591
3879
1.71
25.47
2.2
1.7
mg/l
1.2
1.1
0.30
437
2904
(3001604) Monocytes [#/volume] in Blood
1135
8768
1.60
25.46
7.3
5.7
e9/l
0.6
0.6
0.44
1044
7618
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
40
61
6.66
25.13
1.1
1.1
ng/l
96.2
333.9
—
6
16
(3022217) INR in Platelet poor plasma by Coagulation assay
329
1817
1.95
24.99
22.1
23.0
inr
1.3
1.3
0.08
47
268
(3019198) Lymphocytes [#/volume] in Blood
1161
9072
1.58
24.39
7.4
5.8
e9/l
1.9
2.0
2.16
1076
8069
(3004789) Transferrin [Mass/volume] in Serum or Plasma
393
2319
1.84
24.31
3.5
2.4
g/l
2.4
2.4
0.13
363
2143
(3004119) Hemoglobin [Mass/volume] in Venous blood
194
893
2.28
23.78
5.0
3.3
g/l
131.3
129.6
0.41
187
870
(3020630) Protein [Mass/volume] in Serum or Plasma
234
1168
2.12
23.46
2.2
2.6
g/l
66.2
66.8
0.57
217
1080
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
233
1163
2.12
23.35
2.8
2.3
ug/l
13.6
6.8
1.60
209
1027
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
35
50
7.10
23.34
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
35
50
7.10
23.34
1.2
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
820
5964
1.59
23.08
4.0
3.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
220
1079
2.15
23.06
7.0
3.8
kpa
5.1
5.2
0.58
209
1015
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
365
2138
1.84
23.02
3.6
2.5
%
24.0
23.6
0.17
301
1845
(3013115) Eosinophils [#/volume] in Blood
1156
9099
1.56
22.97
7.6
6.0
e9/l
0.2
0.2
0.46
1070
8062
(3022948) Iron [Moles/volume] in Serum or Plasma
414
2533
1.78
22.57
3.5
2.4
umol/l
13.4
13.6
0.26
382
2340
(3013650) Neutrophils [#/volume] in Blood by Automated count
1257
10108
1.56
22.50
10.0
8.7
e9/l
4.1
4.1
0.66
1163
8825
(3033658) Prothrombin time (PT) actual/Normal
611
4164
1.64
22.34
7.1
3.8
%
89.0
90.7
0.80
594
4053
(3042733) HLA Ab [Presence] in Serum
36
56
6.52
22.21
3.4
4.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
137
557
2.55
22.09
1.6
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
215
1066
2.12
21.89
7.1
3.9
ph
7.4
7.4
0.36
33
127
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
210
1032
2.14
21.88
7.1
3.8
mmol/l
1.7
1.7
0.04
144
761
(3024354) Oxygen [Partial pressure] in Venous blood
237
1222
2.05
21.74
6.1
3.3
kpa
4.9
4.7
1.09
227
1183
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
46
93
5.03
21.62
1.6
1.5
u/l
5.7
6.8
0.34
39
76
(3007853) Bacteria identified in Skin by Aerobe culture
346
2030
1.83
21.61
2.0
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
856
6385
1.55
21.07
2.3
1.9
pmol/l
96.3
95.5
0.21
518
3474
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
53
6.50
20.93
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
130
533
2.53
20.60
1.6
1.6
g/l
1.1
1.2
1.21
125
505
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
34
54
6.38
20.56
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
625
4357
1.60
20.54
2.8
2.2
mg/l
3.0
2.9
0.41
560
3712
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
409
2558
1.73
20.47
2.1
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
126
512
2.55
20.34
1.6
1.6
g/l
0.2
0.2
1.41
121
486
(3015235) Bicarbonate [Moles/volume] in Capillary blood
109
414
2.72
20.15
4.0
3.0
mmol/l
23.2
24.9
2.55
97
368
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
129
533
2.51
20.11
2.5
2.3
ug/l
457.1
498.9
0.10
119
502
(3026782) Osmolality of Urine
497
3291
1.66
20.04
3.4
2.7
mosm/kgh2o
528.8
559.6
2.41
434
2788
(3047181) Lactate [Moles/volume] in Blood
118
468
2.61
20.02
10.7
7.4
mmol/l
1.5
1.3
0.44
104
397
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
218
1126
2.04
19.86
1.9
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
111
429
2.67
19.83
1.7
2.1
mg/l
11.1
11.1
0.03
105
398
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
38
70
5.50
19.80
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
32
51
6.35
19.29
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
577
3999
1.60
19.23
3.5
3.0
ng/l
1488.7
1441.4
0.09
488
3355
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
126
526
2.48
19.22
1.6
1.6
titre
80.0
200.0
—
5
14
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
27
37
7.37
18.66
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
54
140
3.93
18.62
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
143
642
2.31
18.55
2.8
2.2
s
21.3
21.3
0.01
126
562
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
127
544
2.41
18.32
1.4
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1371
11531
1.49
17.74
5.7
4.0
e6/l
875.3
1900.0
0.60
24
141
(3022096) Basophils/100 leukocytes in Blood
1012
8029
1.48
17.54
7.7
5.9
%
0.6
0.7
1.86
972
7510
(4062490)
56
157
3.63
17.29
1.9
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
121
521
2.40
17.26
3.6
2.8
g/l
3.2
3.6
2.66
113
493
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
82
291
2.89
17.24
1.6
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
141
650
2.25
17.19
1.6
1.4
u/l
9.2
9.0
0.08
120
523
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
112
467
2.47
17.14
4.4
3.6
u/ml
0.3
0.3
1.07
71
263
(3039000) Anion gap in Blood
86
315
2.80
17.06
13.1
9.4
mmol/l
11.8
11.7
0.08
76
277
(3019069) Monocytes/100 leukocytes in Blood
1043
8355
1.46
17.03
8.2
6.1
%
8.3
8.4
0.47
1004
7849
(3029937) Albumin [Presence] in Urine by Test strip
636
4611
1.53
17.02
4.9
3.5
estimate
0.0
0.0
1.49
238
1653
(3018572) Chloride [Moles/volume] in Blood
86
316
2.79
16.96
13.1
9.4
mmol/l
105.9
105.5
0.23
76
278
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
442
2954
1.62
16.85
4.6
3.4
ng/l
969.2
439.7
0.63
295
2090
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
165
819
2.10
16.70
7.0
4.3
mmol/l
23.4
24.0
1.49
152
749
(3020191) Ethanol [Moles/volume] in Serum or Plasma
52
142
3.73
16.69
1.5
1.5
promille
0.7
1.3
2.30
44
114
(3006504) Eosinophils/100 leukocytes in Blood
1033
8300
1.45
16.38
7.9
5.9
%
2.7
2.8
0.66
989
7741
(3000850) Epithelial cells [#/volume] in Urine
508
3539
1.56
16.16
3.2
2.4
e6/l
6.0
6.4
0.22
454
3102
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
302
1848
1.73
16.08
7.6
6.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
514
3594
1.56
16.08
1.7
1.5
nmol/l
20.2
20.3
0.06
456
3108
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
36
77
4.74
15.89
2.7
2.4
umol/l
57.7
47.1
1.20
30
60
(3028192) IgG subclass 2 [Mass/volume] in Serum
54
157
3.50
15.81
1.7
1.3
g/l
2.9
2.8
0.04
42
110
(3002582) Erythrocytes [#/volume] in Urine
679
5063
1.49
15.63
4.0
3.1
e6/l
43.7
88.9
1.40
564
3889
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
65
215
3.08
15.49
1.4
1.3
nmol/l
0.1
0.4
—
6
12
(3007164) IgA [Mass/volume] in Serum or Plasma
523
3699
1.54
15.46
1.7
1.5
g/l
2.4
2.3
0.17
360
2296
(3002030) Lymphocytes/100 leukocytes in Blood
1062
8637
1.44
15.45
7.9
5.9
%
27.4
28.5
2.91
1019
8095
(3048689) Calprotectin [Mass/mass] in Stool
356
2306
1.65
15.27
2.1
2.5
ug/g
127.6
120.0
0.10
266
1832
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
32
64
5.06
15.26
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
60
191
3.20
15.24
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
45
119
3.84
15.13
1.7
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1470
12718
1.45
15.11
5.0
3.8
mm/h
11.0
10.9
0.05
1385
11756
(3024139) IgG subclass 3 [Mass/volume] in Serum
53
157
3.43
15.10
1.7
1.3
g/l
0.4
0.4
0.13
41
109
(3027135) IgG subclass 1 [Mass/volume] in Serum
53
157
3.43
15.10
1.7
1.3
g/l
6.3
6.7
0.25
40
112
(3017143) Hepatitis C virus Ab [Presence] in Serum
374
2460
1.62
15.07
1.7
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
17
10.07
14.92
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
153
771
2.06
14.87
14.7
12.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
122
565
2.23
14.72
3.1
2.5
%
87.9
91.6
0.82
117
533
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
117
533
2.26
14.69
1.9
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
42
110
3.87
14.33
1.3
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1040
8504
1.42
14.27
7.9
5.7
%
57.9
56.9
2.25
998
7986
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
79
306
2.64
14.11
1.4
1.4
u/l
19.4
20.4
0.09
70
257
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
203
1148
1.84
14.06
2.5
2.2
u/l
3786.6
5508.8
0.48
65
467
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1559
13717
1.45
14.04
5.0
3.9
pmol/l
14.7
14.6
0.66
1464
12588
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
282
1764
1.68
13.76
2.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
58
193
3.06
13.71
1.4
1.3
nmol/l
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
361
2426
1.58
13.18
2.0
1.8
%
1.5
1.4
2.04
321
2149
(3019150) Specific gravity of Urine by Refractometry
511
3713
1.49
12.99
4.9
3.5
kg/l
1.0
1.0
0.21
70
539
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
95
419
2.32
12.89
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
837
6673
1.41
12.87
4.7
3.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
195
1120
1.81
12.83
5.1
4.1
ng/l
95.9
84.9
0.72
169
995
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
276
1753
1.66
12.67
2.0
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1024
8462
1.39
12.67
4.3
2.8
ug/l
104.9
108.3
0.25
958
7884
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
121
594
2.10
12.63
10.4
6.3
%
1.7
1.6
0.41
110
548
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
568
4238
1.46
12.55
1.4
1.3
u/ml
1.7
1.6
0.04
176
1104
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
15
16
9.43
12.55
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
25
48
5.26
12.49
3.7
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
119
586
2.09
12.32
10.7
6.3
%
1.3
0.9
0.83
109
541
(3037467) Urinalysis macro (dipstick) panel - Urine
1397
12179
1.39
12.32
5.4
4.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
211
1256
1.75
12.30
5.3
3.5
mmol/l
1.2
1.2
0.91
188
1069
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
147
783
1.94
12.23
11.1
10.9
mmol/l
23.9
24.4
1.11
137
742
(3024980) IgG subclass 4 [Mass/volume] in Serum
68
263
2.64
12.22
1.6
1.7
g/l
0.6
0.8
0.93
50
202
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
83
354
2.40
12.16
7.8
6.0
iu/ml
858.9
452.5
0.38
17
46
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
172
967
1.84
12.13
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1036
8629
1.37
11.97
4.4
3.3
estimate
0.0
0.0
0.80
241
1665
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
199
1176
1.76
11.89
3.4
2.8
ng/l
185.0
189.8
0.06
176
1065
(3030467) Casts [#/volume] in Urine by Automated count
606
4618
1.43
11.84
3.7
3.0
e6/l
0.4
0.4
0.27
495
3476
(3015736) pH of Urine
829
6673
1.38
11.76
4.0
3.1
—
5.5
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
64
245
2.66
11.75
2.5
2.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
27
59
4.62
11.65
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
28
64
4.42
11.45
3.4
2.8
—
—
—
0
0
(3024471) HLA-A [Type]
27
60
4.54
11.42
1.1
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
32
83
3.90
11.11
1.2
1.4
nmol/l
131.1
141.8
0.68
32
83
(3024869) Neuronal Ab [Presence] in Serum
17
25
6.84
11.02
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
60
230
2.65
11.01
2.5
1.4
mmol/l
76.5
67.9
0.53
51
187
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
22
7.32
10.99
1.1
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
760
6084
1.38
10.96
4.7
3.5
e6/l
70.2
95.4
0.49
587
4186
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
59
225
2.67
10.94
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
72
303
2.42
10.89
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
147
815
1.86
10.85
3.5
2.6
e6/l
0.3
0.2
0.25
142
786
(36304419) Bacteria [Presence] in Urine
591
4547
1.41
10.78
3.7
2.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
116
596
2.00
10.73
2.9
1.9
ug/l
1.9
1.8
0.01
103
526
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
51
182
2.84
10.72
1.6
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1033
8696
1.35
10.72
4.5
3.3
estimate
0.0
0.0
0.80
238
1643
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
290
1939
1.57
10.71
5.3
2.8
umol/l
9.9
8.2
0.39
240
1668
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
101
494
2.09
10.68
8.0
4.6
mg/l
1.7
1.5
1.26
94
456
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
32
86
3.76
10.59
1.1
1.1
miu/ml
1656.1
1545.3
0.18
32
86
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
23
7.00
10.57
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
80
359
2.27
10.48
2.9
3.8
%
58.7
57.2
0.49
80
359
(3025941) Bacteria identified in Stool by Culture
176
1042
1.75
10.45
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
263
1731
1.59
10.39
2.9
2.7
%
1.8
1.7
0.15
221
1558
(3021601) Nitrite [Presence] in Urine by Test strip
1022
8617
1.34
10.37
5.7
4.5
estimate
0.0
0.0
0.50
245
1715
(3007566) Smooth muscle Ab [Titer] in Serum
97
473
2.10
10.35
1.3
1.3
titre
72.7
91.6
0.38
11
44
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
41
132
3.15
10.31
1.8
2.2
%
15.6
12.6
0.30
23
70
(3042936) Bacteria identified in Isolate by Culture
336
2340
1.51
10.29
2.5
2.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
82
375
2.23
10.28
1.4
1.5
nmol/l
0.3
0.4
0.50
69
313
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
985
8272
1.34
10.21
4.9
4.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
35
103
3.44
10.15
1.7
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
540
4128
1.41
10.13
5.1
4.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
591
4589
1.39
10.11
2.0
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
685
5458
1.37
9.97
2.9
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
392
2835
1.46
9.94
3.0
2.9
mmol/l
2.4
2.4
0.45
329
2467
(3030905) Polymorphonuclear cells [#/volume] in Blood
77
349
2.25
9.87
2.7
3.5
e9/l
4.2
4.2
0.06
77
349
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
22
6.86
9.73
1.1
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
176
1068
1.70
9.57
1.6
1.4
iu/l
18.2
23.4
1.75
152
898
(3000570) Elastase.pancreatic [Mass/mass] in Stool
90
440
2.09
9.56
1.4
1.4
ug/g
319.4
298.6
0.37
50
236
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
18
33
5.49
9.45
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
197
1237
1.65
9.41
2.4
2.6
e9/l
69.7
70.5
0.11
155
939
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
27
70
3.89
9.41
1.0
1.0
ng/l
1658.4
311.0
0.51
20
51
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
249
1659
1.56
9.31
4.4
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
138
789
1.80
9.25
8.4
4.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1577
17091
0.74
9.21
22.5
13.2
%
39.5
40.1
1.97
1103
13103
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
65
284
2.33
9.10
1.3
1.2
u/ml
2.1
5.2
1.60
30
103
(40761535) Cells panel - Urine sediment
202
1289
1.62
9.06
4.3
3.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
76
356
2.17
9.02
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
80
383
2.13
8.99
1.6
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
156
932
1.72
8.99
1.7
1.6
mu/l
332.8
295.7
0.55
139
840
(40767503) Oxygen content in Capillary blood by calculation
74
344
2.19
8.95
3.4
2.5
%
17.4
16.3
1.47
42
183
(3013512) EKG study
563
4414
1.37
8.90
4.2
3.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
73
3.73
8.89
1.5
2.9
umol/l
73.4
127.2
0.75
14
41
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
203
3053
0.63
8.85
2.7
3.0
ug/l
0.6
0.8
2.39
133
1957
(3044007) Cell count panel - Peritoneal fluid
21
47
4.50
8.83
4.9
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
43
4.68
8.82
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
45
168
2.71
8.75
2.3
2.6
e9/l
1.4
1.2
0.65
31
99
(3000963) Hemoglobin [Mass/volume] in Blood
1938
20275
0.67
8.74
31.4
18.3
g/l
133.9
135.8
6.24
1915
19994
(3010813) Leukocytes [#/volume] in Blood
1938
20272
0.67
8.68
31.2
18.3
e9/l
7.0
6.8
3.81
1894
19720
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
96
499
1.97
8.65
2.3
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
62
272
2.32
8.62
4.0
3.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
26
70
3.75
8.62
1.0
1.0
ng/l
36.8
44.3
0.38
18
48
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
26
70
3.75
8.62
1.0
1.0
ng/l
740.9
668.3
0.30
20
50
(3047007) Chlamydophila sp Ab [Presence] in Serum
66
298
2.25
8.58
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1938
20267
0.68
8.57
31.2
18.2
e12/l
4.5
4.5
6.93
1892
19719
(3035941) MCH [Entitic mass]
1938
20265
0.68
8.53
31.0
18.1
pg
30.2
30.2
0.69
1918
19986
(3024731) MCV [Entitic volume]
1938
20264
0.68
8.51
31.0
18.2
fl
90.6
90.5
0.59
1919
19987
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
41
148
2.80
8.50
1.1
1.3
—
250.0
—
0
6
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
148
2.80
8.50
1.1
1.3
titre
71.0
260.0
—
10
30
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
29
85
3.44
8.50
1.3
1.6
nmol/l
1.2
1.7
0.44
23
62
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
16
7.54
8.41
1.0
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
17
33
5.18
8.40
1.6
1.5
g/l
16.9
25.9
—
8
26
(3004588) Protein electrophoresis panel - Serum or Plasma
154
935
1.69
8.38
2.0
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
66
302
2.22
8.32
3.2
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
113
629
1.84
8.28
2.1
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1361
12173
1.30
8.17
4.9
3.0
u/l
52.7
44.3
3.05
1283
11472
(3007461) Platelets [#/volume] in Blood
1938
20246
0.68
8.14
31.2
18.2
e9/l
253.4
253.1
0.07
1899
19741
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
89
461
1.97
8.11
2.3
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
41
152
2.73
8.10
1.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
41
154
2.69
7.91
1.1
1.1
mg/l
268.3
292.5
1.25
36
138
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
21
52
4.07
7.80
4.7
1.9
e6/l
2390.9
30825.9
0.50
16
37
(3037121) Protein [Mass/volume] in Urine
107
601
1.82
7.64
3.1
3.4
g/l
0.4
0.3
0.83
60
251
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
57
255
2.27
7.61
1.1
1.1
g/l
1.6
1.5
0.31
48
233
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
519
4112
1.34
7.50
2.8
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
545
4350
1.33
7.49
7.9
6.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
186
1220
1.57
7.45
1.4
1.3
u/ml
344.0
211.1
0.40
166
1128
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
25
73
3.45
7.39
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
61
286
2.16
7.29
1.3
1.3
u/ml
3.2
4.8
0.79
34
132
(3010375) cycloSPORINE [Mass/volume] in Blood
26
79
3.32
7.24
38.6
28.3
ug/l
116.7
130.7
0.51
21
66
(40768797) Stomach Pathology biopsy report
309
2262
1.42
7.23
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
511
1.86
7.14
1.6
2.3
g/l
2.9
3.1
0.98
66
416
(3023511) Choriogonadotropin [Units/volume] in Urine
108
623
1.77
7.08
1.5
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
117
693
1.73
7.00
9.7
4.2
mmol/l
24.6
24.8
0.21
111
653
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
76
3.32
6.97
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
35
4.60
6.93
6.4
7.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
273
2.15
6.88
1.3
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
491
3909
1.33
6.79
4.3
3.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
542
1.81
6.78
1.6
2.3
g/l
6.9
7.3
1.09
66
430
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
542
1.81
6.78
1.6
2.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
14
28
5.03
6.70
3.5
3.7
umol/l
48.1
46.1
0.14
14
22
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
14
7.17
6.70
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
54
250
2.19
6.68
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1890
17874
1.37
6.61
25.5
13.8
mmol/l
139.4
139.6
2.97
1864
17368
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
95
542
1.79
6.49
1.6
2.3
g/l
3.6
3.8
0.65
64
405
(3041096) Erythrocytes [Presence] in Urine by Automated
594
4885
1.29
6.43
3.8
3.0
—
—
—
0
0
(3019225) pH of Specimen
217
1519
1.47
6.43
4.4
4.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
202
1394
1.49
6.42
4.5
4.1
%
0.8
0.9
0.44
52
389
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1605
17130
0.78
6.40
4.5
3.9
mmol/l
1.4
1.5
10.89
1508
15921
(3026389) Candida sp identified in Specimen by Organism specific culture
48
216
2.25
6.37
1.6
1.2
—
—
—
0
0
(4306422)
58
282
2.08
6.36
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
56
3.59
6.31
1.7
2.3
e6/l
325.8
207.1
0.36
12
31
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
63
317
2.02
6.30
1.5
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
140
2126
0.64
6.29
1.3
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
38
4.23
6.28
1.5
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
57
280
2.06
6.10
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1891
17934
1.35
6.09
25.1
13.9
mmol/l
3.9
4.0
0.78
1859
17395
(4010399)
165
1107
1.53
6.00
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1620
17234
0.78
5.99
4.5
3.9
mmol/l
4.5
4.7
5.52
1520
16108
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
17
44
3.89
5.99
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
13
27
4.84
5.97
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
13
27
4.84
5.97
1.2
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
184
1265
1.50
5.97
4.5
4.2
%
0.0
0.6
0.97
42
307
(3021589) Normoblasts [#/volume] in Blood
907
7907
1.25
5.94
12.9
8.9
e9/l
0.0
0.0
0.34
799
6428
(3044889) 12 lead EKG panel
1271
11498
1.24
5.94
4.1
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1649
17498
0.78
5.91
4.8
4.3
mmol/l
2.7
2.8
2.29
1543
16224
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
28
101
2.79
5.89
1.2
1.1
ratio
1.1
1.0
—
9
39
(36660697) Celiac disease serology panel - Serum
210
1488
1.45
5.85
1.2
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
36
4.19
5.82
1.0
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
9
11.15
5.79
1.2
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
137
2.50
5.78
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
137
2.50
5.78
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
137
2.50
5.78
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
137
2.50
5.78
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
137
2.50
5.78
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
30
114
2.65
5.74
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
110
678
1.65
5.73
2.0
2.0
g/l
1.3
1.4
1.38
95
597
(3021440) Promyelocytes/100 leukocytes in Blood
191
1335
1.47
5.71
4.4
4.2
%
0.1
0.1
0.23
49
363
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
308
1.97
5.71
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
138
2.49
5.70
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
221
1589
1.43
5.70
4.8
3.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
17
5.90
5.63
1.1
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
32
127
2.54
5.62
2.5
2.8
e9/l
0.2
0.2
0.04
25
113
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
122
1855
0.64
5.52
1.7
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
80
457
1.78
5.49
2.3
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
558
6636
0.79
5.49
2.7
2.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
129
2.50
5.45
2.5
2.8
e6/l
633.7
565.3
0.27
25
113
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
460
3730
1.29
5.45
1.8
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
20
62
3.25
5.45
1.5
3.4
mg/l
9806.5
83.6
0.48
15
47
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
380
3009
1.32
5.36
1.3
1.3
iu/ml
34.0
28.0
0.32
87
917
(3002179) Metamyelocytes/100 leukocytes in Blood
182
1279
1.46
5.31
4.0
3.9
%
0.6
0.6
0.13
38
290
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
81
470
1.75
5.29
1.5
2.5
g/l
0.7
1.0
0.38
69
420
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
74
2.99
5.26
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
26
4.63
5.26
5.1
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
31
126
2.48
5.21
2.4
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
66
362
1.85
5.19
2.8
2.3
g/l
133.0
131.1
0.21
56
280
(4198724)
26
97
2.70
5.17
1.6
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
511
1.71
5.17
1.6
2.3
g/l
10.6
10.5
0.05
69
444
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
74
422
1.78
5.13
1.4
2.3
g/l
0.0
0.0
0.72
66
392
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
40
184
2.20
5.10
1.4
1.4
pmol/l
295.8
327.2
0.31
35
140
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
51
258
2.00
5.09
1.1
1.8
—
1270.0
—
0
8
(3009508) Creatinine [Moles/volume] in Urine
585
4928
1.25
5.03
3.4
3.3
mmol/l
7.4
8.0
2.03
506
4172
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
9
9
10.03
5.02
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
32
4.08
4.89
6.2
7.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
137
2.36
4.83
1.5
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
24
4.60
4.78
3.0
2.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
57
308
1.87
4.72
1.1
1.1
iu/ml
19.8
1579.1
0.54
14
85
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
49
905
0.53
4.72
1.5
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
332
2625
1.31
4.72
3.5
2.8
e6/l
4.0
2.5
1.25
201
1429
(3004809) Band form neutrophils/100 leukocytes in Blood
49
252
1.97
4.70
2.6
3.8
%
1.8
1.3
0.38
39
209
(3024928) Oxygen saturation in Venous blood
60
331
1.84
4.67
4.1
3.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
332
4137
0.77
4.66
3.7
4.1
%
21.9
21.5
0.17
137
1912
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
21
74
2.86
4.65
1.6
1.6
iu/ml
—
881935.7
—
0
7
(3019977) pH of Arterial blood
22
80
2.77
4.61
1.8
3.3
ph
7.4
7.4
—
6
25
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
11
8.21
4.56
1.2
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
33
148
2.25
4.50
2.5
2.3
%
36.0
43.4
—
5
23
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
44
3.43
4.46
1.7
2.7
ug/l
76.4
82.7
0.07
15
44
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
175
1263
1.42
4.46
2.7
2.6
ml/min/173m2
66.8
70.2
0.57
84
484
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
45
3.35
4.32
1.4
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
35
698
0.49
4.31
1.5
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
22
4.56
4.30
2.0
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
35
165
2.14
4.25
1.7
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
52
283
1.86
4.25
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
34
681
0.49
4.25
1.4
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
72
432
1.69
4.24
1.4
2.3
g/l
37.1
37.8
0.25
59
384
(3021879) Hepatitis B virus core Ab [Presence] in Serum
213
1605
1.36
4.20
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1559
16470
0.82
4.15
4.1
3.5
mmol/l
1.4
1.3
4.39
1457
15230
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
351
2845
1.28
4.12
1.3
1.2
u/ml
5.4
11.4
1.14
136
1127
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
54
301
1.81
4.10
1.6
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
93
601
1.57
4.09
2.1
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
23
4.36
4.09
6.3
8.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
63
2.87
4.06
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
77
477
1.64
4.03
3.5
3.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
9
14
6.45
3.98
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
35
677
0.51
3.96
1.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
212
1.95
3.92
1.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
206
1.96
3.87
1.8
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
230
1777
1.33
3.86
1.3
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
54
2.98
3.85
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
107
724
1.50
3.84
2.6
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
40
207
1.95
3.83
1.8
2.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
29
3.81
3.80
1.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
339
2763
1.27
3.79
3.1
2.7
e6/l
1.3
1.2
0.12
209
1562
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
54
309
1.77
3.79
1.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
5
12.03
3.76
1.3
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
5
12.03
3.76
2.0
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
54
310
1.76
3.75
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
99
663
1.52
3.74
2.4
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
37
189
1.97
3.68
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
100
674
1.51
3.67
1.4
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
9
16
5.64
3.66
1.1
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
31
149
2.10
3.63
3.6
3.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
66
405
1.65
3.62
1.9
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
67
413
1.64
3.61
1.8
1.7
—
—
—
0
0
(4268621)
40
212
1.90
3.59
2.4
2.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
502
4301
1.22
3.54
3.0
2.6
umol/l
3351.0
5494.6
0.58
447
3767
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
57
2.82
3.52
1.3
1.5
—
—
—
0
0
(4034850)
82
535
1.55
3.50
14.9
8.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
442
5175
0.82
3.50
3.8
4.8
ug/l
1.7
2.8
4.87
387
4623
(44790047)
38
200
1.92
3.49
1.4
1.6
—
—
—
0
0
(44790048)
38
200
1.92
3.49
1.4
1.6
—
—
—
0
0
(44790049)
38
200
1.92
3.49
1.4
1.6
—
—
—
0
0
(44806118)
38
200
1.92
3.49
1.4
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
111
773
1.46
3.48
2.3
2.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
12
36
3.35
3.47
1.0
1.2
umol/24h
0.6
0.7
—
7
18
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
72
457
1.59
3.46
1.3
1.2
u/ml
2.1
6.9
—
9
73
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
49
823
0.59
3.45
1.4
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1710
16310
1.20
3.44
6.0
4.5
mu/l
1.8
2.0
0.98
1616
15097
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
146
2.07
3.42
2.4
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
202
1.90
3.40
1.9
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
329
0.36
3.35
1.8
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
206
1601
1.32
3.34
3.0
2.4
u/l
30.8
68.7
0.69
178
1363
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
50
827
0.60
3.33
1.4
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
399
1.62
3.32
1.4
2.3
g/l
0.0
0.0
0.00
57
372
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
74
478
1.57
3.32
1.5
2.0
iu/l
2.3
4.7
4.79
20
179
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
76
494
1.56
3.32
1.3
1.2
u/ml
11.7
43.1
—
7
26
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
50
826
0.60
3.31
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
50
826
0.60
3.31
1.4
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
33
169
1.97
3.29
2.5
4.8
u/ml
103.8
98.0
0.04
11
49
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
248
1.79
3.29
1.6
1.7
—
—
—
0
0
(4035726)
181
1385
1.33
3.27
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
38
205
1.87
3.26
1.9
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
38
205
1.87
3.26
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
38
205
1.87
3.26
1.9
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
60
2.68
3.22
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
38
206
1.86
3.22
1.9
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
38
206
1.86
3.22
1.9
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
64
403
1.61
3.20
1.4
2.3
g/l
0.0
0.0
0.00
57
373
(3017732) Neutrophils [#/volume] in Blood
160
1207
1.35
3.19
3.0
2.8
e9/l
4.3
4.2
0.25
127
996
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
451
1.57
3.19
1.3
1.2
u/ml
45.4
2.5
—
7
39
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
11
6.38
3.18
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
44
2.97
3.13
1.7
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
116
1590
0.71
3.12
1.4
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
130
952
1.39
3.12
1.1
1.1
—
124.5
—
0
19
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
20
4.51
3.11
1.1
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
113
809
1.42
3.09
2.0
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1862
17958
1.22
3.07
22.4
12.5
mg/l
20.9
23.1
2.36
1583
14006
(3051651) Icteric interference index of Serum or Plasma
22
99
2.23
3.06
3.6
3.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1506
15820
0.85
3.06
26.9
15.5
g/l
333.3
333.0
0.52
1500
15692
(3029075) Extractable nuclear Ab panel - Serum
15
56
2.69
3.06
1.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
8
7.52
3.05
1.3
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
90
1284
0.69
3.05
1.4
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
16
62
2.59
3.04
2.4
1.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
45
262
1.73
3.04
1.4
1.2
u/l
28.6
38.9
0.30
40
223
(3045424) Erythrocytes [Presence] in Urine
48
286
1.69
2.99
1.4
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
57
2.64
2.96
1.1
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
248
2009
1.26
2.94
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
174
1348
1.32
2.91
2.6
2.1
nmol/l
11.5
12.3
0.61
145
1201
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
37
206
1.81
2.91
1.2
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
42
243
1.74
2.91
1.2
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
30
3.34
2.90
7.4
6.2
—
—
—
0
0
(4281824)
30
157
1.92
2.85
1.5
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
298
1.66
2.84
2.0
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
83
2.30
2.84
1.7
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
123
2.04
2.81
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
467
4056
1.19
2.81
2.0
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
314
0.41
2.78
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
123
913
1.37
2.75
1.6
1.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
6
8.35
2.75
2.4
4.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
6
8.35
2.75
2.4
4.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
13
48
2.72
2.72
1.2
1.1
u/ml
46.7
43.4
0.05
13
48
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
48
2.72
2.72
2.1
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
83
577
1.46
2.70
1.5
1.6
iu/ml
0.4
10.8
0.48
25
113
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
59
382
1.56
2.68
1.3
1.2
u/ml
58.6
38.9
—
7
36
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
119
2.03
2.66
1.1
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
56
360
1.57
2.63
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
56
360
1.57
2.63
1.6
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
25
127
1.98
2.60
3.7
3.2
mg/l
23.1
30.9
0.22
16
96
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
18
373
0.48
2.60
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
344
2926
1.21
2.60
2.3
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
95
684
1.41
2.57
1.7
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
24
121
1.99
2.55
1.4
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
7
7.15
2.55
1.8
5.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
126
952
1.34
2.54
2.0
2.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
62
2.43
2.54
2.1
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
151
1.87
2.47
1.1
1.2
u/l
82.4
57.7
0.76
23
110
(3000764) Benzodiazepines [Presence] in Urine
133
1019
1.32
2.45
2.0
2.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
44
272
1.63
2.44
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
83
2.18
2.41
1.7
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
190
1.75
2.37
1.1
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
8
6.26
2.37
4.8
3.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
139
1.88
2.36
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
511
4537
1.16
2.34
4.4
4.1
mg/mmol
19.4
9.7
1.91
348
2950
(3028300) Cannabinoids [Presence] in Urine
133
1028
1.31
2.32
2.1
2.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
25
133
1.89
2.31
12.5
12.1
mmol/l
0.6
0.6
0.09
25
119
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
112
1.97
2.30
1.9
2.9
%
40.0
42.4
0.19
12
40
(3037756) Immunofixation for Serum or Plasma
44
277
1.60
2.29
1.5
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
145
1137
1.29
2.28
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
16
72
2.23
2.27
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
23
3.49
2.27
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
487
4320
1.16
2.25
3.5
3.3
mg/l
879.3
288.8
1.15
325
2822
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1243
13110
0.88
2.23
3.7
3.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
47
303
1.56
2.22
3.0
3.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
132
1026
1.30
2.22
2.0
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
130
1009
1.31
2.21
2.0
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
28
158
1.78
2.17
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
30
3.01
2.14
2.7
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
68
2.21
2.11
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
68
2.21
2.11
1.6
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
138
1.82
2.09
1.4
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
124
1.86
2.07
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
133
1048
1.29
2.04
1.1
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
74
534
1.40
2.04
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
125
1.85
2.02
1.3
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
59
410
1.45
2.00
2.6
3.3
mg/l
66.2
66.0
0.00
49
330
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
24
133
1.81
1.99
2.0
1.6
g/l
0.9
1.0
0.09
24
133
(3014765) Yersinia sp identified in Stool by Organism specific culture
73
528
1.40
1.99
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
38
240
1.59
1.99
1.2
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
15
70
2.15
1.98
2.1
2.2
nmol/l
184.8
147.6
0.59
15
61
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
59
411
1.45
1.97
2.6
3.3
mg/l
36.3
64.7
0.47
49
332
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
7
21
3.34
1.96
1.4
1.6
nmol/l
6.6
564289.5
—
7
14
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
16
3.76
1.93
2.0
2.2
ug/g
119.7
128.5
—
6
16
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
16
3.76
1.93
1.2
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
195
1.65
1.93
1.8
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
746
6882
1.13
1.90
2.3
2.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
28
2.86
1.86
2.1
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
17
3.54
1.84
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
72
528
1.38
1.83
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
29
2.76
1.79
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
18
3.34
1.74
4.3
2.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
117
1.80
1.74
1.6
2.1
u/field
3.9
2.3
0.37
12
59
(3008898) HLA-B27 [Presence]
97
751
1.30
1.74
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
36
2.51
1.74
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
36
2.51
1.74
2.8
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
178
1.64
1.73
2.2
4.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
24
2.92
1.72
1.1
1.4
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
13
3.85
1.71
2.6
3.2
mmol/l
13.7
19.2
—
5
13
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
13
3.85
1.71
1.4
6.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
61
2.14
1.71
1.3
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
48
2.30
1.70
1.9
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
48
2.30
1.70
1.9
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
111
1.81
1.68
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
111
1.81
1.68
1.1
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
185
1552
1.21
1.67
1.9
1.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
12
240
0.50
1.66
2.6
3.7
u/ml
20.8
31.1
0.54
12
233
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
19
3.16
1.66
1.0
1.3
umol/24h
1.6
1.8
—
6
19
(3003888) Timothy IgE Ab [Units/volume] in Serum
60
435
1.39
1.66
1.1
1.1
u/ml
2.7
6.2
2.53
34
243
(3032057) Clostridioides difficile [Presence] in Stool
8
31
2.59
1.66
1.9
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
157
1.66
1.65
2.3
3.5
%
65.9
53.8
2.46
19
113
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
90
696
1.31
1.64
1.5
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
32
2.51
1.59
1.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
97
763
1.28
1.57
1.5
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
44
2.28
1.53
2.0
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
45
315
1.44
1.53
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
53
383
1.39
1.51
3.6
4.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
7
27
2.60
1.51
3.9
3.7
g/mol
32.2
42.8
—
7
22
(44806071)
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
70
530
1.33
1.50
2.4
3.6
u/ml
64.6
2658.4
0.76
56
447
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
369
3305
1.14
1.50
1.6
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
147
1.64
1.47
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
364
3263
1.14
1.46
2.4
2.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
132
1.67
1.46
3.3
2.8
e6/l
667.7
691.1
—
7
55
(3052592) Norovirus Ag [Presence] in Stool
7
28
2.50
1.45
1.4
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
227
1969
1.17
1.44
2.0
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
22
2.73
1.43
1.8
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
22
2.73
1.43
1.2
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
39
2.31
1.43
1.0
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
103
1.75
1.41
1.7
1.5
u/l
4.2
5.8
—
9
50
(40761511) CBC panel - Blood by Automated count
1854
18910
0.89
1.36
20.6
11.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
143
1.61
1.35
2.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
143
1.61
1.35
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
143
1.61
1.35
2.1
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
20
120
1.67
1.34
4.3
3.0
%
13.6
11.2
1.28
20
120
(3034426) Prothrombin time (PT)
12
61
1.97
1.32
1.3
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
40
0.00
1.32
0.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
136
1.62
1.32
1.3
1.3
pmol/l
79.4
63.8
0.23
12
44
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
106
1.70
1.29
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
58
439
1.33
1.28
1.4
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
19
2.64
1.21
1.4
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
37
2.17
1.21
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
88
712
1.25
1.19
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
60
771
0.77
1.19
1.4
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
86
1.75
1.19
1.1
1.2
u/l
27.4
18.2
0.50
15
75
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
86
1.75
1.19
1.2
1.1
iu/ml
362.4
206.0
0.40
15
86
(3001556) Androgen free Index in Serum or Plasma
6
26
2.31
1.18
1.3
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
368
1.34
1.16
1.6
1.7
—
—
—
0
0
(3036603) Volume of Urine
17
102
1.67
1.16
1.5
1.5
ml
1806.3
1938.0
—
6
19
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
39
2.05
1.15
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
167
1444
1.17
1.14
2.7
4.2
ug/l
10.3
24.2
1.00
134
1159
(3008401) Mugwort IgE Ab [Units/volume] in Serum
55
422
1.31
1.14
1.1
1.1
u/ml
0.8
1.4
0.46
26
185
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
58
1.90
1.12
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
51
1.97
1.11
1.8
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
354
1.33
1.11
4.8
2.6
nmol/l
1.1
0.8
1.25
41
303
(3042111) Morphology [Interpretation] in Bone marrow Narrative
35
251
1.40
1.10
1.2
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
84
1025
0.81
1.09
1.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
104
1.64
1.09
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
95
784
1.22
1.09
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
89
1.69
1.07
1.1
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
61
769
0.79
1.06
2.1
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
52
1.93
1.06
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
178
1.47
1.05
4.0
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
14
82
1.71
1.05
1.3
1.7
—
—
—
0
0
(4094501)
53
411
1.30
1.03
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
54
421
1.29
1.02
1.1
1.1
u/ml
2.6
2.7
0.02
14
107
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1585
15467
1.08
1.00
6.0
5.0
mmol/mol
38.8
39.0
0.34
1492
14403
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
68
1.77
1.00
2.2
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
109
0.46
1.00
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
55
695
0.79
0.99
1.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
97
813
1.20
0.98
2.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
308
2808
1.11
0.97
1.6
1.7
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
18
116
1.56
0.96
1.0
1.2
—
4.6
—
0
7
(3000492) Spirometry study
203
1807
1.14
0.96
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
149
1.48
0.95
1.6
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
19
125
1.52
0.94
1.0
1.2
—
44.1
—
0
9
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
126
1.51
0.91
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
176
1.43
0.90
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
11
63
1.75
0.90
1.2
1.6
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
29
2.07
0.89
1.2
1.1
u/ml
0.1
0.6
—
6
21
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
135
1.49
0.89
1.6
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
30
2.00
0.87
1.2
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1869
18961
0.91
0.86
13.8
9.2
u/l
28.8
26.3
2.71
1819
18327
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
44
1.82
0.86
1.3
2.2
umol/l
18.0
16.2
—
8
44
(3015183) Erythrocyte sedimentation rate
6
114
0.53
0.83
1.2
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
18
121
1.49
0.82
1.0
1.1
—
13.7
—
0
6
(3001019) Free T4 and TSH panel - Serum or Plasma
99
1152
0.85
0.82
2.1
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
12
73
1.65
0.81
1.0
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
73
1.65
0.81
1.2
1.2
—
60.0
—
0
12
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
89
1.58
0.81
1.1
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
48
383
1.26
0.80
1.6
1.3
ug/l
2.7
3.6
0.83
42
355
(3014891) Appearance of Pleural fluid
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
48
1.67
0.78
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
125
0.56
0.77
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
115
1.48
0.76
1.3
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
24
2.09
0.74
1.4
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
24
2.09
0.74
1.2
3.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
17
116
1.47
0.74
1.8
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
24
176
1.37
0.72
1.1
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
24
176
1.37
0.72
1.8
2.2
mg/l
7.4
19.9
—
8
49
(44813793)
18
126
1.43
0.70
1.1
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
77
1.56
0.68
3.2
4.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
161
1.37
0.68
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
102
1.47
0.67
4.8
7.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
276
1.27
0.66
1.3
1.4
mmol/l
7.4
7.1
0.16
29
196
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
94
0.53
0.66
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
45
368
1.23
0.64
3.4
3.3
mg/l
25.1
26.2
0.07
28
236
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
57
478
1.20
0.63
1.2
1.1
u/ml
0.7
1.7
0.98
24
205
(3002385) Erythrocyte distribution width [Ratio]
1510
15378
0.94
0.63
25.3
15.0
%
13.7
13.6
4.28
1491
15033
(3042631) Mycobacterium sp identified in Specimen
27
208
1.30
0.62
1.7
2.7
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
30
1.67
0.61
1.2
1.1
u/ml
0.0
1.6
—
5
24
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.7
—
6.6
—
0
7
(3051101) Glucose [Moles/volume] in Cord blood
0
20
0.00
0.60
0.0
5.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
131
1.38
0.59
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
149
1.35
0.57
1.2
1.3
u/ml
0.2
0.7
—
6
65
(3024891) Influenza virus A+B Ag [Presence] in Specimen
64
549
1.17
0.57
1.4
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
40
328
1.22
0.57
1.2
1.1
u/ml
4.7
5.0
0.04
15
134
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
17
230
0.74
0.57
1.5
1.6
mmol/l
7.8
7.4
0.27
12
138
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
36
1.67
0.56
1.3
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
124
1.37
0.55
1.2
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
82
1.47
0.54
2.4
2.4
ug/l
17.7
118.4
0.51
12
71
(3008536) Aspergillus sp Ab [Presence] in Serum
6
38
1.58
0.54
3.0
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
43
358
1.21
0.54
1.2
1.1
u/ml
5.4
4.2
0.15
18
136
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
40
1.50
0.51
2.8
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
126
1.35
0.51
2.1
1.9
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
11
76
1.45
0.48
1.1
1.2
u/ml
1.6
40.6
—
6
46
(21494890) Protein electrophoresis panel - 24 hour Urine
19
146
1.30
0.47
2.3
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
146
1.30
0.47
3.9
4.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.47
3.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.47
3.1
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.47
3.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.47
3.1
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
111
1.35
0.46
1.5
2.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
82
0.61
0.45
1.2
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
19
147
1.30
0.45
1.2
1.1
u/ml
0.8
1.9
—
6
42
(3044242) Glucose [Moles/volume] in Arterial blood
12
86
1.40
0.44
2.0
2.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
69
1.45
0.44
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
51
1.37
0.44
1.3
1.4
ug/l
8.3
8.6
—
7
51
(3015076) Soybean IgE Ab [Units/volume] in Serum
18
139
1.30
0.43
1.2
1.1
u/ml
0.1
4.2
—
5
20
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
78
1.41
0.43
2.3
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
207
0.77
0.42
1.5
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
58
1.38
0.41
1.4
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
71
1.41
0.39
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
232
2196
1.06
0.37
1.3
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
3.7
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
3.7
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
53
598
0.88
0.36
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
70
1.29
0.36
3.7
1.9
—
—
—
0
0
(4146454)
19
153
1.24
0.35
2.6
2.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
285
1.16
0.32
1.1
1.0
u/ml
2.4
2.2
—
10
138
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
86
795
1.09
0.29
1.2
1.3
miu/ml
248.7
224.3
0.15
23
393
(3000475) Leukocytes [#/volume] in Synovial fluid
39
345
1.13
0.28
1.4
1.7
e6/l
7465.1
15230.1
1.41
29
260
(3017569) Oxygen content in Arterial blood
10
76
1.32
0.28
1.9
2.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
149
1.21
0.27
1.1
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
33
375
0.88
0.27
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
33
375
0.88
0.27
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
41
366
1.12
0.27
1.6
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1635
16488
0.97
0.26
17.7
11.2
ml/min/173m2
87.5
86.2
1.29
1413
13440
(3036071) Salmonella sp Ab [Titer] in Serum
10
77
1.30
0.26
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
170
1.18
0.24
1.6
1.6
%
58.0
55.9
0.07
11
116
(3045788) Cell count panel - Pleural fluid
11
137
0.80
0.24
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
116
1095
1.06
0.24
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
578
0.91
0.23
2.1
2.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
17
143
1.19
0.23
1.1
1.1
u/ml
0.7
4.1
—
7
50
(4015189)
5
38
1.32
0.23
1.8
2.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
40
1.25
0.22
1.6
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
200
1922
1.04
0.22
4.2
4.0
%
30.8
31.7
0.66
154
1329
(3022621) pH of Urine by Test strip
116
1100
1.06
0.21
3.0
2.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
12
0.00
0.21
0.0
2.0
—
2.1
—
0
12
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.6
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.1
—
44.1
—
0
14
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
41
374
1.10
0.20
1.6
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
176
0.85
0.20
1.1
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
70
655
1.07
0.20
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
193
1.14
0.19
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
34
308
1.11
0.19
1.1
1.0
u/ml
0.2
0.3
—
6
73
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
154
0.84
0.19
1.2
1.4
e6/l
309380.0
96403.8
—
6
89
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
43
395
1.09
0.19
1.3
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
58
1.21
0.18
1.6
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
58
1.21
0.18
6.3
3.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
142
0.84
0.17
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
63
1.11
0.17
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
369
1.09
0.16
2.9
2.4
ug/min
136.7
137.0
0.00
27
230
(3012441) Differential panel - Pleural fluid
18
158
1.14
0.16
1.6
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
92
1.20
0.16
1.6
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
92
1.20
0.16
1.6
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
551
5598
0.98
0.15
1.6
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
232
2384
0.97
0.15
1.7
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
245
1.10
0.15
2.9
3.2
nmol/l
0.8
0.8
0.46
20
188
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
83
791
1.05
0.15
1.9
1.7
mg/l
5.1
4.1
0.34
60
541
(40765089) Chromosome analysis panel - Blood by G-banded
7
90
0.78
0.14
1.1
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
160
1.13
0.14
1.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
377
0.93
0.13
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
132
1.14
0.13
3.7
2.1
—
—
—
0
0
(4024509)
15
132
1.14
0.13
1.8
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
182
1.10
0.11
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
37
393
0.94
0.10
1.8
1.9
—
—
—
0
0
(4133840)
5
45
1.11
0.09
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
46
1.09
0.09
27.2
19.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
43
409
1.05
0.09
1.4
1.5
pmol/l
70.9
124.7
1.03
43
400
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1675
16696
1.01
0.08
4.7
4.0
mmol/l
5.9
5.8
0.81
1562
15355
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
15
136
1.10
0.08
1.1
1.1
iu/ml
9.6
8.9
—
6
33
(3047189) Immunofixation for 24 hour Urine
5
63
0.79
0.08
1.6
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
66
1.06
0.08
2.4
4.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
74
0.81
0.07
2.3
2.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
82
0.85
0.07
3.6
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
29
305
0.95
0.06
2.0
1.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
37
355
1.04
0.06
3.4
2.1
umol/l
9.8
6.7
0.42
30
261
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
313
0.96
0.05
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
27
258
1.05
0.04
1.4
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
231
0.95
0.04
1.1
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
81
796
1.02
0.03
3.1
3.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
435
4329
1.01
0.03
1.7
1.6
mmol/l
1.5
1.4
2.36
378
3679
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
191
1.05
0.03
1.5
1.4
mmol/l
9.5
12.3
—
6
40
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
154
1.04
0.00
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
40
394
1.02
0.00
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
155
0.97
0.00
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
220
2201
1.00
0.00
1.9
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
108
1.02
0.00
1.6
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
78
0.90
0.00
2.7
1.7
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
165.8
—
0
5
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
76
0.92
0.00
2.3
3.3
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
174.6
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
0.2
—
0
5
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
67
0.90
0.00
1.0
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_CERCYST and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CERCYST | 3.663 [3.19, 4.21] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.072 |
During the follow-up period (1.1.1998 — 31.12.2019), 1185 out of 5799 females with G6_CERCYST died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CERCYST | 3.775 [3.36, 4.24] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 2063 out of 6201 males with G6_CERCYST died.
Mortality risk
Mortality risk for people of age
years, who have G6_CERCYST.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.347% | 0.85% |
| 5 | 2.303% | 4.934% |
| 10 | 5.1% | 11.518% |
| 15 | 9.267% | 21.045% |
| 20 | 15.851% | 33.472% |
Relationships between endpoints
↥Index endpoint: G6_CERCYST – Cerebral cysts
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data